 |
| March
12, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
- Alphyn: Completes Enrollment in CLEAR-AD1
Global Phase 2b Clinical Trial of Novel
Topical for Atopic Dermatitis More
- FDA: Launches New Adverse Event Look-Up Tool
More
More*
More*
- Gain Therapeutics: Presentations at AD/PDTM
2026 and U.S. FDA Regulatory Update More
- Precision for Medicine: Continues
Asia-Pacific Expansion With Opening of Japan
Office More
- Quoin Pharmaceuticals: FDA Grants
Fast Track Designation for QRX003 for the
Treatment of Netherton Syndrome
More
- REGENXBIO: New Positive Interim Data
From Phase I/II Affinity Duchenne Trial of
RGX-202 More
More
- United Therapeutics: Full Results of TETON-2
Phase 3 Clinical Trial Published in The New
England Journal of Medicine More
|
|
|
|
- Despite Delays, NIH Grants Generated a 250%
Return on $36.6B Investment in 2025: Report More
- Elutia: Fourth Quarter and Full Year 2025
Financial Results; Initiates NXT-41 Regulatory
Process More
- Galimedix Therapeutics: Earns
Milestone Payment in Ophthalmology
Partnership With Théa Open Innovation More
- GeneDx: Landmark Study Shows Average Cost
Savings of $80,000 Per Child and Overall
Improved Health Outcomes Following GeneDx
Exome and Genome Testing More
- Theriva Biologics: Full-Year 2025
Operational Highlights and Financial Results
More
|
|
 |
| Struggling
to get attention for your
products and services?
Break through with high-impact
marketing content and campaigns |
|
Learn More
→ |
|
|
- Nanoparticles Trigger In Vivo CAR T Cell
Generation to Eliminate B Cells
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Thinking Differently in Uncertain Times:
Fulton Bank’s Bret Schreiber on Capital,
Community, and the Future of Maryland Life
Sciences More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibilities More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- Lilly Plucks Flagship, Bluebird Vet for
Regenerative Medicine Unit; Novo’s New China
President More*
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
